No attention-boosting drugs for healthy kids, doctors urge

Doctors at Yale School of Medicine and the American Academy of Neurology (AAN) have called upon their fellow physicians to limit or end the practice of prescribing memory-enhancing drugs to healthy children whose brains are still developing. Their position statement is published in the March 13 online issue of the journal Neurology, the medical journal of the AAN.

The statement was written to address the growing trend in which teens use "study drugs" before tests and parents request (ADHD) drugs for who don't meet the criteria for the disorder. The AAN spent several years analyzing all of the available research and to develop this official position statement on the topic.

"Doctors caring for children and teens have a professional obligation to always protect the best interests of the child, to protect vulnerable populations, and to prevent the misuse of medication," said first author of the statement, William Graf, M.D., professor of pediatrics and neurology at Yale School of Medicine. "The practice of prescribing these drugs, called neuroenhancements, for healthy students is not justifiable."

Graf and a group of child neurologists provide evidence that points to dozens of ethical, legal, social, and developmental reasons why prescribing mind-enhancing drugs, such as those used to treat ADHD, for healthy people is viewed differently in children and adolescents than it would be in functional, independent adults with full decision-making capacities.

Some of the reasons not to prescribe neuroenhancements include: the child's best interest; the long-term health and safety of neuroenhancements, which has not been studied in children; kids and teens may lack complete decision-making capacities while their judgments and are still developing; maintaining doctor-patient trust; and the risks of over-medication and dependency.

"A physician should talk to the child about the request, as it may reflect other medical, social, or psychological motivations such as anxiety, depression, or insomnia," said Graf, who notes that there are alternatives to neuroenhancements available, including maintaining good sleep, nutrition, study habits, and exercise regimens.

More information: Neurology 80 (March 13, 2013) neurology.org/lookup/doi/10.1212/WNL.0b013e318289703b

Related Stories

Physicians should not prescribe ADD drugs to healthy people

Dec 17, 2012

Physicians in Canada should consider refusing to prescribe cognitive enhancement medications—also used to treat attention deficit disorder (ADD)—to healthy patients, states an analysis article in CMAJ (Canadian Medical A ...

Epilepsy drug may increase risk of autism in children

Dec 01, 2008

A new study shows that women who take the epilepsy drug valproate while pregnant may significantly increase their child's risk of developing autism. The preliminary research is published in the December 2, 2008, print issue ...

Recommended for you

Know the brain, and its axons, by the clothes they wear

1 hour ago

(Medical Xpress)—It is widely know that the grey matter of the brain is grey because it is dense with cell bodies and capillaries. The white matter is almost entirely composed of lipid-based myelin, but ...

Turning off depression in the brain

21 hours ago

Scientists have traced vulnerability to depression-like behaviors in mice to out-of-balance electrical activity inside neurons of the brain's reward circuit and experimentally reversed it – but there's ...

Rapid whole-brain imaging with single cell resolution

22 hours ago

A major challenge of systems biology is understanding how phenomena at the cellular scale correlate with activity at the organism level. A concerted effort has been made especially in the brain, as scientists are aiming to ...

User comments